Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01612923
Other study ID # W2010U
Secondary ID
Status Completed
Phase Phase 3
First received June 4, 2012
Last updated August 25, 2013
Start date April 2011
Est. completion date July 2012

Study information

Verified date June 2012
Source Karolinska Institutet
Contact n/a
Is FDA regulated No
Health authority Sweden: Regional Ethical Review Board
Study type Interventional

Clinical Trial Summary

The physical examination before an abortion is usually performed by a physician. However, in many countries access to physicians is limited. To increase access to safe abortion this study wishes to examine if midlevel providers such as specially trained midwives can provide safe abortion services. Midwives in study were specially trained to perform early pregnancy ultrasound and if needed to consult a physician. The midwife then provided the abortion service as well as the contraceptive advice. Women were randomized to receive the service from a midwife or a physician.


Recruitment information / eligibility

Status Completed
Enrollment 1180
Est. completion date July 2012
Est. primary completion date June 2012
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- healthy women aged 18-45 with no contraindication to medical abortion

Exclusion Criteria:

- any medical condition which contraindicates medical abortion

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Midwife
gynecological exam and ultrasound and contraceptive advice provided by midwife

Locations

Country Name City State
Sweden Karolinska University Hospital Stockholm

Sponsors (1)

Lead Sponsor Collaborator
Kristina Gemzell Danielsson

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary feasibility Successful completion of abortion without need for unscheduled visits or calls. 3 weeks Yes
Secondary efficacy complete uterine evacuation without the need for further medical or surgical intervention 3 weeks Yes
Secondary acceptability as assessed by questionnaire 3 weeks No
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02745093 - Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks Phase 4
Completed NCT02570204 - Self-Assessment of Medical Abortion Outcome Using Serial Multi-level Pregnancy Tests N/A
Completed NCT01487213 - Routine Follow-up Versus Self-assessment in Medical Abortion N/A
Terminated NCT05119439 - Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks Phase 4
Terminated NCT04941443 - Methadone and Medication Abortion Phase 4
Completed NCT02985229 - Acceptability and Feasibility of Medical Abortion in Singapore Phase 3
Completed NCT01920022 - Quickstart of Nexplanon® at Medical Abortion Phase 4
Completed NCT00472394 - Determining Women's Preferences for Medical Abortion Using Willingness to Pay N/A
Completed NCT03604341 - Cannabinoids for Pain Control During Medical Abortion Phase 4
Completed NCT00907725 - Does Follow-up With Serum Beta Human Chorionic Gonadotropin (BhCG) Simplify Medical Abortion? N/A
Completed NCT00120224 - De-Medicalizing Mifepristone Medical Abortion N/A
Completed NCT03148587 - Medical Abortion Self-Confirmation (MASC) N/A
Completed NCT00621543 - Insertion of an Intrauterine Device (IUD) After Medical Abortion N/A
Completed NCT02343913 - Simplifying Menstrual Regulation (MR): Post Abortion Care in Pakistan N/A
Completed NCT01856777 - Effectiveness of Pregnancy Tests as an Assessment Tool to Identify Continuing Pregnancy N/A
Recruiting NCT00920465 - Treatment Regimens for Mifegyne and Cytotec Phase 3
Completed NCT05532085 - Assessment of Pain During an Abortion With Knowledge of the Predictive Factors of Pain.
Completed NCT00997347 - The Extended Gestational Age Medical Abortion Study Phase 4
Completed NCT03014193 - Simplifying First Trimester Medical Abortion Follow-up N/A
Recruiting NCT04905251 - Effectiveness and Safety of Combination Mifepristone/Misoprostol for Medical Abortion